BNIP1
Reaktivität: Human
WB
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
For WB starting dilution is: 1:1000
For IHC-P starting dilution is: 1:50~100
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1.93 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target
BNIP1
(BCL2/adenovirus E1B 19kDa Interacting Protein 1 (BNIP1))
NIP1 antikoerper, SEC20 antikoerper, TRG-8 antikoerper, 2010005M06Rik antikoerper, 5930429G21Rik antikoerper, Sec20 antikoerper, bnip1 antikoerper, BCL2 interacting protein 1 antikoerper, BCL2/adenovirus E1B interacting protein 1 antikoerper, BCL2/adenovirus E1B 19kDa interacting protein 1 S homeolog antikoerper, BNIP1 antikoerper, Bnip1 antikoerper, bnip1.S antikoerper
Hintergrund
NIP1 (BNIP1) is a member of the BCL2/adenovirus E1B 19 kd-interacting protein (BNIP) family. It interacts with the E1B 19 kDa protein which is responsible for the protection of virally-induced cell death, as well as E1B 19 kDa-like sequences of BCL2, also an apoptotic protector. Alternative splicing of this gene results in four products of unknown function. Transcript variant BNIP1 contains the entire coding region of the gene. This variant contains a fully conserved BH3 domain, which has been associated with pro-apoptotic function.